Aquaculture Vaccines Market – By Vaccine Type, By Route of Administration, By Application, By Species – Global Forecast, 2025 – 2034

Key players in the sector include CIBA, HIPRA, Kyoto Biken Laboratories, Kemin Industries, Kyoritsuseiyaku Corporation, Merck Animal Health (a division of Merck & Co.), Nisseiken, Phibro Animal Health Corporation, Tecnovax, Virbac, and Veterquimica.

The European region dominates the aquaculture vaccines industry, with Norway's market valued at USD 85.4 million in 2024, driven by its robust aquaculture industry, particularly in salmon farming.

The inactivated vaccine segment was valued at USD 302.6 million in 2024, holding a significant market share due to its proven safety and efficacy in protecting fish populations against various bacterial and viral diseases.

The global aquaculture vaccines industry was valued at USD 407.4 million in 2024 and is estimated to grow at a CAGR of 8% from 2025 to 2034, driven by increasing global demand for seafood and sustainable aquaculture practices.